Cutting the supply of prescription opioids has been a popular intervention to fight the drug crisis. But, according to a study released last week by the Journal of the American Medical Association, these interventions are likely to cut opioid deaths by only 3 to 6 percent by 2025.
Seventy percent of doctors and pharmacists believe they have dispensed opioids to a person with an opioid use disorder, according to a new survey of medical professionals.
Sens. Chuck Grassley (R., Iowa) and Amy Klobuchar (D., Minn.) are testing the waters of the 116th Congress for support of importing drugs from Canada, an effort to combat exploding prescription costs.
New York’s Metropolitan Museum of Art is considering dropping long-time major donors, the Sackler family, after new reporting indicates they were more closely tied to their company’s role in the opioid crisis than previously thought.
Pharmaceutical firms’ direct marketing to doctors continues to cause prescription opioid deaths, a new study argues.
The Sackler family, owners of Purdue Pharma, were far more closely tied to the marketing of deadly opioids than previously thought, new documents released in a Massachusetts lawsuit suggest.
As America’s drug crisis booms, the RAND Corporation released a report Thursday calling for clinical trials testing the effectiveness of doctor-administered heroin to treat opioid-use disorders.
China will finally add fentanyl and its analogs to its list of controlled substances, following a Saturday meeting between Chinese president Xi Jinping and President Donald Trump.
Test strips designed to detect the presence of fentanyl in drug doses may help to encourage safer drug consumption, new research suggests.
Attorney General Jeff Sessions announced Thursday more than $60 million in new grants to combat the drug crisis, capping off a week of federal action on the issue.